At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create,
Sherwood Pharmaceuticals is a young startup exploring the first-ever treatment for Cri du Chat syndrome, a rare genetic disease. At Sherwood Pharmaceuticals we are assessing a drug repurposing opportunity for the potential treatment of Cri du